Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-14

Clinical Trial Update: Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study

View source ↗

Summary

The GIANT-B genetic study evaluating peginterferon treatment for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peginterferon (Pegylated interferon)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis B | Status: COMPLETED